Support Alert

Drug Safety Update: montelukast (Singulair) - reminder of the risk of neuropsychiatric reactions

The Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update highlights new and updated advice.

Some of our content, including support alerts, is only available to RPS members. 

Log in

Find out more about membership of the Society